Methoxyamine potentiation of temozolomide anti-cancer activity
US6465448B1 · kind B1 · utility
21Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 1999 |
| Grant date | Oct 15, 2002 |
| Priority date | — |
| Expiry date | Aug 13, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention generally relates to novel compositions and methods for the treatment of certain cancers. Additionally, this invention relates to novel compositions and methods to screen drugs for the treatment of certain cancers. Specifically, the invention contemplates that temozolomide and methoxyamine, in combination or in sequence, shall be used as a treatment for certain tumors that are resistant to treatment by temozolomide alone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.